Strict blood pressure control associates with decreased mortality risk by APOL1 genotype
- 1 February 2017
- journal article
- Published by Elsevier in Kidney International
- Vol. 91 (2) , 443-450
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD ProgressionClinical Journal of the American Society of Nephrology, 2015
- Apolipoprotein L1-Associated Nephropathy and the Future of Renal DiagnosticsJournal of the American Society of Nephrology, 2015
- Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal diseaseKidney International, 2015
- End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1Arthritis & Rheumatology, 2013
- Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African AmericansKidney International, 2013
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Regional Variation in Health Care Intensity and Treatment Practices for End-stage Renal Disease in Older AdultsJAMA, 2010
- Identifying a National Death Index MatchAmerican Journal of Epidemiology, 2009
- The conundrum of increased burden of end-stage renal disease in AsiansKidney International, 2005